Conclusion Fibromyalgia is increasingly recognized as a disorder driven by oxidative stress, mitochondrial dysfunction, and neuroinflammation, contributing to pain amplification and fatigue
Future developments may include: Combination Therapies: Pairing BPC 157 with other growth factors, stem cell therapy, and platelet-rich plasma (PRP) to amplify regenerative effects
When sleep becomes chronically compromised, the body's antioxidant systems may be forced to work harder to maintain balance
Proper laboratory handling procedures and sterile techniques should always be followed during use
25 A subsequent single-center placebo-controlled, multiple-ascending dose, phase 1b trial examined the safety, tolerability, pharmacokinetics, and pharmacodynamics of cagrilintide in combination with semaglutide